{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T08:23:40Z","timestamp":1778574220731,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00417-022-05585-x","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T07:02:36Z","timestamp":1646118156000},"page":"3061-3068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Mammalian target of rapamycin inhibitors for the treatment of astrocytic hamartoma in tuberous sclerosis complex (TSC)"],"prefix":"10.1007","volume":"260","author":[{"given":"Ofri","family":"Vorobichik Berar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Tzadok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofira","family":"Zloto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iris","family":"Moroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idan","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Ampaire","family":"Musika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer","family":"Shlomovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido-Didi","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9203-8097","authenticated-orcid":false,"given":"Vicktoria","family":"Vishnevskia Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,1]]},"reference":[{"key":"5585_CR1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.pcl.2015.03.005","volume":"62","author":"FJ DiMario","year":"2015","unstructured":"DiMario FJ, Sahin M, Ebrahimi-Fakhari D (2015) Tuberous sclerosis complex. Pediatr Clin North Am 62:633\u2013648. https:\/\/doi.org\/10.1016\/j.pcl.2015.03.005","journal-title":"Pediatr Clin North Am"},{"key":"5585_CR2","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.3928\/19382359-20170320-01","volume":"46","author":"SC Randle","year":"2017","unstructured":"Randle SC (2017) Tuberous sclerosis complex: a review. Pediatr Ann 46:e166\u2013e171. https:\/\/doi.org\/10.3928\/19382359-20170320-01","journal-title":"Pediatr Ann"},{"key":"5585_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"372","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, Bombardieri R, Jozwiak S (2008) Tuberous sclerosis. Lancet 372:657\u2013668. https:\/\/doi.org\/10.1016\/S0140-6736(08)61279-9","journal-title":"Lancet"},{"key":"5585_CR4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"P Curatolo","year":"2015","unstructured":"Curatolo P, Moavero R, de Vries PJ (2015) Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 14:733\u2013745. https:\/\/doi.org\/10.1016\/S1474-4422(15)00069-1","journal-title":"Lancet Neurol"},{"key":"5585_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1136\/archdischild-2013-304948","volume":"100","author":"KH Ng","year":"2015","unstructured":"Ng KH, Ng SM, Parker A (2015) Annual review of children with tuberous sclerosis. Arch Dis Child Educ Pract Ed 100:114\u2013121. https:\/\/doi.org\/10.1136\/archdischild-2013-304948","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"5585_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1136\/bjo.85.4.420","volume":"85","author":"SA Rowley","year":"2001","unstructured":"Rowley SA, O\u2019Callaghan FJ, Osborne JP (2001) Ophthalmic manifestations of tuberous sclerosis: a population based study. Br J Ophthalmol 85:420\u2013423. https:\/\/doi.org\/10.1136\/bjo.85.4.420","journal-title":"Br J Ophthalmol"},{"key":"5585_CR7","first-page":"1","volume":"1","author":"P Carrai","year":"2015","unstructured":"Carrai P, Giuliari GP, Shields CL et al (2015) Optical coherence tomography classification and correlation with tuberous sclerosis complex. Retina 1:1\u201310","journal-title":"Retina"},{"key":"5585_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0002-9394(14)71174-2","volume":"119","author":"IE Zimmer-Galler","year":"1995","unstructured":"Zimmer-Galler IE, Robertson DM (1995) Long-term observation of retinal lesions in tuberous sclerosis. Am J Ophthalmol 119:318\u2013324. https:\/\/doi.org\/10.1016\/S0002-9394(14)71174-2","journal-title":"Am J Ophthalmol"},{"key":"5585_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/j.1600-0420.2006.00781.x","volume":"85","author":"S Mennel","year":"2007","unstructured":"Mennel S, Meyer CH, Peter S et al (2007) Current treatment modalities for exudative retinal hamartomas secondary to tuberous sclerosis: review of the literature. Acta Ophthalmol Scand 85:127\u2013132. https:\/\/doi.org\/10.1111\/j.1600-0420.2006.00781.x","journal-title":"Acta Ophthalmol Scand"},{"key":"5585_CR10","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1755-3768.2008.01331.x","volume":"88","author":"W Saito","year":"2010","unstructured":"Saito W, Kase S, Ohgami K et al (2010) Intravitreal anti-vascular endothelial growth factor therapy with bevacizumab for tuberous sclerosis with macular oedema. Acta Ophthalmol 88:377\u2013380. https:\/\/doi.org\/10.1111\/j.1755-3768.2008.01331.x","journal-title":"Acta Ophthalmol"},{"key":"5585_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3928\/23258160-20121221-19","volume":"44","author":"M Lonngi","year":"2013","unstructured":"Lonngi M, Gold AS, Murray TG (2013) Combined bevacizumab and triamcinolone acetonide injections for macular edema in a patient with astrocytic hamartomas and tuberous sclerosis. Ophthalmic Surg Lasers Imaging Retina 44:85\u201390. https:\/\/doi.org\/10.3928\/23258160-20121221-19","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"5585_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4255\/mcpharmacol.09.16","volume":"1","author":"L-H Zeng","year":"2009","unstructured":"Zeng L-H, Rensing NR, Wong M (2009) Developing antiepileptogenic drugs for acquired epilepsy: targeting the mammalian target of rapamycin (mTOR) Pathway. Mol Cell Pharmacol 1:124\u2013129. https:\/\/doi.org\/10.4255\/mcpharmacol.09.16","journal-title":"Mol Cell Pharmacol"},{"key":"5585_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0158476","volume":"11","author":"DN Franz","year":"2016","unstructured":"Franz DN, Belousova E, Sparagana S et al (2016) Long-term use of everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study. PLoS ONE 11:1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0158476","journal-title":"PLoS ONE"},{"key":"5585_CR14","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA French","year":"2016","unstructured":"French JA, Lawson JA, Yapici Z et al (2016) Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet 388:2153\u20132163. https:\/\/doi.org\/10.1016\/S0140-6736(16)31419-2","journal-title":"Lancet"},{"key":"5585_CR15","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1016\/j.ophtha.2015.03.023","volume":"122","author":"ZQ Zhang","year":"2015","unstructured":"Zhang ZQ, Shen C, Long Q et al (2015) Sirolimus for retinal astrocytic hamartoma associated with tuberous sclerosis complex. Ophthalmology 122:1947\u20131949. https:\/\/doi.org\/10.1016\/j.ophtha.2015.03.023","journal-title":"Ophthalmology"},{"key":"5585_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1749-6632.2009.05117.x","volume":"1184","author":"KA Orlova","year":"2010","unstructured":"Orlova KA, Crino PB (2010) The tuberous sclerosis complex. Ann N Y Acad Sci 1184:87\u2013105. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05117.x","journal-title":"Ann N Y Acad Sci"},{"key":"5585_CR17","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/ceo.12806","volume":"45","author":"N Hodgson","year":"2017","unstructured":"Hodgson N, Kinori M, Goldbaum MH, Robbins SL (2017) Ophthalmic manifestations of tuberous sclerosis: a review. Clin Exp Ophthalmol 45:81\u201386. https:\/\/doi.org\/10.1111\/ceo.12806","journal-title":"Clin Exp Ophthalmol"},{"key":"5585_CR18","doi-asserted-by":"publisher","first-page":"e13265","DOI":"10.1097\/MD.0000000000013265","volume":"97","author":"S Yan","year":"2018","unstructured":"Yan S, Chen Y, Chen R et al (2018) Subthreshold micropulse laser photocoagulation therapy in a case of bilateral retinal astrocytic hamartomas with tuberous sclerosis complex: A case report. Med (United States) 97:e13265. https:\/\/doi.org\/10.1097\/MD.0000000000013265","journal-title":"Med (United States)"},{"key":"5585_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00347-010-2156-1","volume":"107","author":"S Mennel","year":"2010","unstructured":"Mennel S, Peter S, Schmidt JC, Meyer CH (2010) Current treatment indications and treatment options for retinal astrocytic hamartoma. Ophthalmologe 107:377\u2013378","journal-title":"Ophthalmologe"},{"key":"5585_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","volume":"381","author":"JJ Bissler","year":"2013","unstructured":"Bissler JJ, Kingswood JC, Radzikowska E et al (2013) Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 381:817\u2013824. https:\/\/doi.org\/10.1016\/S0140-6736(12)61767-X","journal-title":"Lancet"},{"key":"5585_CR21","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jaapos.2017.04.012","volume":"21","author":"N Nallasamy","year":"2017","unstructured":"Nallasamy N, Seider MI, Gururangan S, Mruthyunjaya P (2017) Everolimus to treat aggressive retinal astrocytic hamartoma in tuberous sclerosis complex. J AAPOS 21:328\u2013331. https:\/\/doi.org\/10.1016\/j.jaapos.2017.04.012","journal-title":"J AAPOS"},{"key":"5585_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaapos.2017.08.009","volume":"22","author":"AB Zipori","year":"2018","unstructured":"Zipori AB, Tehrani NN, Ali A (2018) Retinal astrocytoma regression in tuberous sclerosis patients treated with everolimus. J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus 22:76\u201379. https:\/\/doi.org\/10.1016\/j.jaapos.2017.08.009","journal-title":"J AAPOS Off Publ Am Assoc Pediatr Ophthalmol Strabismus"},{"key":"5585_CR23","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1097\/IAE.0000000000001095","volume":"36","author":"C Brockmann","year":"2016","unstructured":"Brockmann C, Rehak M, Heufelder J et al (2016) Predictors of treatment response of vasoproliferative retinal tumors to ruthenium-106 brachytherapy. Retina 36:2384\u20132390. https:\/\/doi.org\/10.1097\/IAE.0000000000001095","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05585-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-022-05585-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-022-05585-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T10:03:25Z","timestamp":1661508205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-022-05585-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["5585"],"URL":"https:\/\/doi.org\/10.1007\/s00417-022-05585-x","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,1]]},"assertion":[{"value":"14 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}